Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b85b68ef371ec9c8ce0c97811ea032a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
filingDate |
2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35187d62ddc0a6b4b46d7c5e12d3979c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a61a7c49780804bff0f48f305d332f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f978f2a74b66e4607c1c50c89ce26c99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e07576ad4d45b2f273c9795451ef0c24 |
publicationDate |
2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-565956-A |
titleOfInvention |
Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
abstract |
Disclosed is a tumour associated peptide according to SEQ ID No. 2 (VMAGDIYSV) or a peptide according to SEQ ID NO. 2, wherein the side chains of one or two amino acid residues are altered, having the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I HLA-A*02. |
priorityDate |
2005-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |